Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | 7819995354 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Lerociclib dihydrochloride | C26H35ClN8O | 2097938-59-3 | Details |
| Lerociclib | C26H34N8O | 1628256-23-4 | Details |
| GABAA receptor agent 1 | C13H8ClN3O2 | 1571-87-5 | Details |
| Amylase | 9000-92-4 | Details |
| gamma-secretase modulator 1 | C24H24N4OS | 1172637-87-4 | Details |
| Gallopamil hydrochloride | C28H41ClN2O5 | 16662-46-7 | Details |
| Gambogellic acid | C38H44O8 | 173867-04-4 | Details |
| Gamitrinib TPP | C52H65N3O8P+ | 1131626-46-4 | Details |
| Gamitrinib TPP hexafluorophosphate | C52H65F6N3O8P2 | 1131626-47-5 | Details |
| Galidesivir triphosphate；BCX6870;Immucillin-A triphosphate;BCX4430-triphosphate | C11H18N5O12P3 | 1467740-78-8 | Details |
| gamma-Secretase Modulators；Amyloid-β production inhibitor;γ-Secretase Modulators | C26H24F3N3O3 | 937812-80-1 | Details |
| gamma-secretase modulator 3 | C24H23FN4OS | 1431697-84-5 | Details |
| gamma-secretase modulator 2 | C25H22F4N6O2 | 1093978-89-2 | Details |
| Gamma-glutamylcysteine TFA；Gamma-glutamylcysteine (TFA);γ-glutamylcysteine (TFA) | C20H32N6O12S2 | 283159-88-6 | Details |
| Clorsulon | C8H8Cl3N3O4S2 | 60200-06-8 | Details |
| GC 14 | C26H27NO6 | 447415-34-1 | Details |
| Ganoderic acid F | C32H42O9 | 98665-15-7 | Details |
| GBR 12783 | C28H32N2O | 67469-57-2 | Details |
| GC7 Sulfate | C8H22N4O4S | 150417-90-6 | Details |
| Glucocorticoid receptor agonist | C20H20F4N2O2 | 1245526-82-2 | Details |
| GLP-1 receptor agonist 1 | C48H48F2N10O5 | 2212020-52-3 | Details |
| GLPG0492 (R enantiomer)；GLPG0492 R enantiomer | C19H14F3N3O3 | 1215085-93-0 | Details |
| Glutaminyl Cyclase Inhibitor 3 | C24H32N6O2S | 2092921-50-9 | Details |
| Glutaminyl Cyclase Inhibitor 2 | C19H20FN3 | 1884546-29-5 | Details |
| Glutaminyl Cyclase Inhibitor 1 | C21H24FN3O2 | 2110449-60-8 | Details |
| GDC-0834 Racemate | C33H36N6O3S | 1133432-46-8 | Details |
| GLP-1 receptor agonist 4 | C51H44Cl2N4O6 | 1187061-62-6 | Details |
| Glucagon receptor antagonists-1 | C29H34FNO2 | 503559-84-0 | Details |
| Gisadenafil besylate；UK 369003-26 | C29H39N7O8S2 | 334827-98-4 | Details |
| Giredestrant；GDC-9545 | C27H31F5N4O | 1953133-47-5 | Details |
| GLP-26 | C19H17F2N3O3 | 2133017-36-2 | Details |
| Gastrofensin AN 5 free base | C19H21ClN2O2 | 89845-16-9 | Details |
| GCN2-IN-1 | C19H18N10O | 1448693-69-3 | Details |
| GLP-1 receptor agonist 2 | C30H31ClFN5O4 | 2230197-64-3 | Details |
| GET73 | C13H16F3NO2 | 202402-01-5 | Details |
| Glutaminase-IN-1；CB839 derivative | C26H24F3N7O3Se | 2247127-79-1 | Details |
| Genz-123346 | C52H82N4O14 | 943344-58-9 | Details |
| Salbutamol；AH-3365;Albuterol | C13H21NO3 | 18559-94-9 | Details |
| Clindamycin phosphate | C18H34ClN2O8PS | 24729-96-2 | Details |
| Glyco-Obeticholic acid | C28H47NO5 | 863239-60-5 | Details |
| Antibacterial compound 2 | C22H30FN5O6 | 170104-58-2 | Details |
| Glucagon receptor antagonists-2 | C22H30FNO2 | 202917-18-8 | Details |
| Glucagon receptor antagonists-3 | C22H30FNO2 | 202917-17-7 | Details |
| Glucagon receptor antagonists-5 | C30H29ClF3N3O3 | 2200274-63-9 | Details |
| GDC-0834 | C33H36N6O3S | 1133432-49-1 | Details |
| Gefitinib N-oxide | C22H24ClFN4O4 | 847949-51-3 | Details |
| Gemcabene calcium；PD-72953 calcium | C16H32CaO5 | 209789-08-2 | Details |
| GLPG0492 | C19H14F3N3O3 | 1215085-92-9 | Details |
| GLPG1205 | C22H22N2O4 | 1445847-37-9 | Details |
| Fenbendazole | C15H13N3O2S | 43210-67-9 | Details |
| O6BTG-octylglucoside；Glucose-conjugated MGMT inhibitor | C24H34BrN5O7S | 382607-78-5 | Details |
| GLUT4 activator 1 | C23H21FN4O3S | 2253733-37-6 | Details |
| Doxycycline hydrochloride；Hyclate;Vibramycin;Doxylin | C22H25ClN2O8 | 10592-13-9 | Details |
| GFB-8438 | C16H14ClF3N4O2 | 2304549-73-1 | Details |
| Garcinol | C38H50O6 | 78824-30-3 | Details |
| GCN2iB | C18H12ClF2N5O3S | 2183470-12-2 | Details |
| Ganoderic acid TR | C30H44O4 | 862893-75-2 | Details |
| Ganodermanontriol | C30H48O4 | 106518-63-2 | Details |
| GB-110 | C33H48N6O5 | 1252806-70-4 | Details |
| Taurocholic acid sodium salt hydrate；Taurocholic Acid sodium hydrate;Sodium taurocholate hydrate | C26H46NNaO8S | 345909-26-4 | Details |
| GDC-0834 S-enantiomer | C33H36N6O3S | 1133432-50-4 | Details |
| GDC-0276 | C24H31FN2O4S | 1494581-70-2 | Details |
| Germacrene D | C15H24 | 23986-74-5 | Details |
| Gepotidacin；GSK2140944 | C24H28N6O3 | 1075236-89-3 | Details |
| GENZ-882706；RA03546849 | C26H25N5O3 | 2070864-35-4 | Details |
| Ginsenoside Ra3 | C59H100O27 | 90985-77-6 | Details |
| GGTI-2418 | C23H31N5O4 | 501010-06-6 | Details |
| Pictilisib dimethanesulfonate | C24H30N7O6S3 | 957054-33-0 | Details |
| GDP-?α-D-?mannose disodium | C16H23N5Na2O16P2 | 148296-46-2 | Details |
| GDP366 | C20H17N5OS | 501698-03-9 | Details |
| Carbenicillin disodium | C17H19N2NaO6S | 4800-94-6 | Details |
| Glyoxalase I inhibitor free base | C21H29BrN4O8S | 174568-92-4 | Details |
| Glycosidase-IN-2 | C13H23NO5 | 476310-39-1 | Details |
| Glycosidase-IN-1 | C13H23NO5 | 170376-12-2 | Details |
| GF 15 | C23H21ClO6 | 888042-13-5 | Details |
| GCN2-IN-6 | C19H12Cl2F2N4O3S | 2183470-09-7 | Details |
| GGTI298 | C27H33N3O3S | 180977-44-0 | Details |
| IPN60090 | C24H27F3N8O3 | 1853164-83-6 | Details |
| Gemilukast | C36H37F2NO5 | 1232861-58-3 | Details |
| GB-88 | C32H42N4O4 | 1416435-96-5 | Details |
| GLP-1 receptor agonist 3 | C31H30FN5O4 | 2230200-09-4 | Details |
| Glycolic acid oxidase inhibitor 1 | C16H10BrNO3 | 77529-42-1 | Details |
| Glucokinase activator 1 | C27H20F2N2O7S2 | 1328987-85-4 | Details |
| GATA4-NKX2-5-IN-1 | C21H23N3O2 | 544681-96-1 | Details |
| Gallopamil | C28H40N2O5 | 16662-47-8 | Details |
| Galanthamine N-Oxide | C17H21NO4 | 134332-50-6 | Details |
| GABAB receptor antagonist 1 | C18H24O4 | 797-17-1 | Details |
| G3-C12 | C74H115N23O23S2 | 848301-94-0 | Details |
| G6PD activator AG1 | C24H30N4S2 | 421581-52-4 | Details |
| G907 | C26H24ClNO3 | 2244035-16-1 | Details |
| GDC-0927；SRN-927 | C28H28FNO4 | 1642297-01-5 | Details |
| Gemfibrozil 1-O-β-glucuronide | C21H30O9 | 91683-38-4 | Details |
| Gefitinib-d8；ZD1839 D8;Gefitinib D8 | C22H24ClFN4O3 | 857091-32-8 | Details |
| Gemcabene | C16H30O5 | 183293-82-5 | Details |
| TT-OAD2 free base | C50H47Cl2N3O6 | 1246826-07-2 | Details |
| Gln-AMS | C15H22N8O8S | 209543-57-7 | Details |
| Glutaminyl Cyclase Inhibitor 4 | C22H33N5O3 | 2376329-36-9 | Details |
| Gly-β-MCA | C26H43NO6 | 66225-78-3 | Details |
| γ-Secretase modulator 4 | C23H19FN4O2 | 1420200-82-3 | Details |
| GKA50 | C26H28N2O6 | 851884-87-2 | Details |
| Product Total： Product Page： | ||||
| 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 | ||||